Delivery Order SPE2DB20D1100-SPE2DB25FD6Y7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clonidine HCL ER 0.1 mg tablets (60-count) with a ceiling value of $2,304.37. The award was issued on July 17, 2025, with an ultimate completion date of July 18, 2025, and utilized firm fixed pricing with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,374.70 to AmerisourceBergen Drug Corp for the supply of Clonidine HCL ER 0.1 mg tablets (60-count packaging). This competitively awarded, firm fixed-price delivery order was issued on November 18, 2025, with an ultimate completion date of November 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating it was competed among all...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Clonidine HCL ER 0.1 mg tablets (60-count units) with a ceiling value of $1,187.00. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside contract with performance executed from the contractor's Conshohocken, Pennsylvania location. The award is a child order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on September 8, 2025, for Clonidine HCl ER 0.17 mg tablets (30-count supply) with a ceiling value of $1,491.84. This firm fixed-price, competitively awarded contract carries an ultimate completion date of September 9, 2025, and involves no set-aside designation. The delivery order represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 7, 2025, for the supply of Clonidine HCL ER 0.1 mg tablets (60-count units) with a ceiling value of $11,427.01. This firm fixed-price delivery order, with an ultimate completion date of June 9, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,292.85 for Clonidine HCL ER 0.1 mg tablets (60-count) with an ultimate completion date of October 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the company's extensive pharmaceutical supply relationship with federal medical procurement systems. The place of performance is the vendor's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Clonidine HCL ER 0.1 mg tablets in a quantity of 60 count, with a ceiling value of $1,012.72. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and was awarded through open competition without a set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,159.04 to AmerisourceBergen Drug Corp for the supply of Clonidine HCL ER 0.1 mg tablets (60-count) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitive award utilizes a firm fixed-price contract structure with no set-aside designation. The product will be delivered to the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clonidine HCl ER 0.1 mg tablets (60-count) on August 27, 2025, with a ceiling value of $4,493.28 and an ultimate completion date of August 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,810.82 firm fixed price delivery order is for the supply of 4564147411 - Clonidine HCL ER 0.1 mg Tablets, 60s. This award is a child order under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6Y7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,184.18 to AmerisourceBergen Drug Corp for the supply of Clonidine HCL ER 0.1 mg tablets (60-count units). The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by July 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The company's substantial IDC vehicle with DLA Troop Support Medical enables it to fulfill diverse pharmaceutical needs across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for Clonidine HCL ER—a medication commonly used in treating hypertension and attention-deficit disorders—exemplifies the company's role in supporting the Defense Health Agency's ongoing medical supply requirements through the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/29/25 |